Drugmakers work on new class of drug to treat diabetes

06/24/2007 | ScientificAmerican.com

Bristol-Myers Squibb and GlaxoSmithKline are working separately to develop a new class of drug to treat a symptom of diabetes. The drugs, called sodium glucose uptake transporter 2 inhibitors, are expected to block the normal tendency of kidneys to reabsorb excess glucose from the body instead excreting it.

View Full Article in:

ScientificAmerican.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC